Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Méglumine antimoniate")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 128

  • Page / 6
Export

Selection :

  • and

PROBLEMES THERAPEUTIQUES DE LA LEISHMANIOSE INFANTILE. A PROPOS DE 125 OBSERVATIONS.EL FEHAIEL A.1975; TUNISIE MED.; TUNISIE; DA. 1975; NO 1; PP. 49-53; BIBL. 12 REF.Article

Glucantime-resistant Leishmania tropica isolated from iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugsHADIGHI, R; BOUCHER, P; KHAMESIPOUR, A et al.Parasitology research (1987). 2007, Vol 101, Num 5, pp 1319-1322, issn 0932-0113, 4 p.Article

Genotoxic effects of the antileishmanial drug glucantime®SOUSA LIMA, Mayara Ingrid; ARRUDA, Viviane Oliveira; CARNEIRO ALVES, Eliza Vanessa et al.Archives of toxicology. 2010, Vol 84, Num 3, pp 227-232, issn 0340-5761, 6 p.Article

Oral delivery of meglumine antimoniate-β-cyclodextrin complex for treatment of leishmaniasisDEMICHELI, Cynthia; OCHOA, Rosemary; DA SILVA, José B. B et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 100-103, issn 0066-4804, 4 p.Article

Etude de la sensibilité au glucantime® de dix souches de Leishmania infantum isolées à Marseille = Glucanthime U2-8 sensitivity of 10 strains of L.i. isolated in MarseilleGAMBARELLI, F; FRANCK, J; DUMON, H et al.Bulletin de la Société française de parasitologie. 1987, Vol 5, Num 1, pp 15-18, issn 0761-8328Article

A PROPOS DE QUELQUES ASPECTS CLINIQUES DE LA LEISHMANIOSE CUTANEE, MALADIE TROP MECONNUE EN REGION PARISIENNE. PROBLEMES DIAGNOSTIQUES ET THERAPEUTIQUELAPIERRE J; PIGUET B; TRAN VINH HIEN et al.1975; SEM. HOP.; FR.; DA. 1975; VOL. 51; NO 8; PP. 531-538; H.T. 1; ABS. ANGL. ESP. ALLEM.Article

UN CAS PROBABLE D'INTOXICATION AIGUEE PAR L'ANTIMOINEBLANC PL; SAUDIN F; WILNER C et al.1980; MED. LEG. TOXICOL.; FRA; DA. 1980; VOL. 23; NO 7; PP. 317-322; BIBL. 8 REF.Article

Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (glucantime®) alone for the treatment of cutaneous leishmaniasisASILIAN, A; SADEGHINIA, A; FAGHIHI, G et al.International journal of dermatology. 2004, Vol 43, Num 4, pp 281-283, issn 0011-9059, 3 p.Article

In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotesMOREIRA, E. S. A; PETRILLO-PEIXOTO, M. L.Brazilian journal of medical and biological research. 1991, Vol 24, Num 5, pp 459-469, issn 0100-879X, 11 p.Article

Leishmania (V.) guyanensis : isolation and characterization of glucantime-resistant cell linesFERREIRA-PINTO, K. C; MIRANDA-VILELA, A. L; ANACLETO, C et al.Canadian journal of microbiology. 1996, Vol 42, Num 9, pp 944-949, issn 0008-4166Article

Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantil visceral leishmaniasis in ItalyDI MARTINO, L; PETTOELLO MANTOVANI, M; GDRADONI, L et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1990, Vol 84, Num 4, pp 534-535, issn 0035-9203Article

Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the KidneysBIANCIARDI, Paolo; BROVIDA, Claudio; VALENTE, Marialuisa et al.Toxicologic pathology. 2009, Vol 37, Num 6, pp 770-775, issn 0192-6233, 6 p.Article

Developmental toxicity of meglumine antimoniate and transplacental transfer of antimony in the ratMIRANDA, Elaine S; MIEKELEY, Norbert; DE-CARVALHO, Rosangela R et al.Reproductive toxicology (Elmsford, NY). 2006, Vol 21, Num 3, pp 292-300, issn 0890-6238, 9 p.Article

Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasisKASHANI, Mansour Nassiri; FIROOZ, Alireza; ESKANDARI, Seyed Ebrahim et al.EJD. European journal of dermatology. 2007, Vol 17, Num 6, pp 513-515, issn 1167-1122, 3 p.Article

Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinolMOMENI, Ali Z; AMINJAVAHERI, Malihalsadat.EJD. European journal of dermatology. 2003, Vol 13, Num 1, pp 40-43, issn 1167-1122, 4 p.Article

APPARENT GLUCANTIME FAILURE IN FIVE PATIENTS WITH MUCOCUTANEOUS LEISHMANIASISROCHA RAA; SAMPAIO RN; GUERRA M et al.1980; J. TROP. MED. HYG.; ISSN 0022-5304; GBR; DA. 1980; VOL. 83; NO 4; PP. 131-139; BIBL. 13 REF.Article

AGRANULOCYTOSE AU COURS D'UNE LEISHMANIOSE VISCERALE TRAITEE PAR LE GLUCANTIME.BOUREE P; DULAC O.1977; ARCH. FR. PEDIATR.; FR.; DA. 1977; VOL. 34; NO 7; PP. 659-662; ABS. ANGL.; BIBL. 6 REF.Article

In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonateEL-ON, J; RUBINSTEIN, N; KERNBAUM, S et al.Annals of tropical medicine and parasitology. 1986, Vol 80, Num 5, pp 509-517, issn 0003-4983Article

LE TRAITEMENT DES LEISHMANIOSES CUTANEES DE L'ANCIEN MONDE: REVUE CRITIQUESTROBEL M; MARCHAND JP; DEDET JP et al.1979; MED. MAL. INFECT.; FRA; DA. 1979; VOL. 9; NO 6; PP. 360-368; ABS. ENG; BIBL. 2 P.Article

THERAPIE DER LEISHMANIA CUTIS = TRAITEMENT DES LEISHMANIOSES CUTANEESMORTAZAWI SAM; AHMADI F; RAHIMI F et al.1979; AKTUELLE DERMATOL.; DEU; DA. 1979; VOL. 5; NO 1; PP. 15-17; ABS. ENG; BIBL. 4 REF.Article

THERAPY OF LEISHMANIASIS: SUPERIOR EFFICACIES OF LIPOSOME-ENCAPSULATED DRUGSALVING CR; STECK EA; CHAPMAN WL JR et al.1978; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1978; VOL. 75; NO 6; PP. 2959-2963; BIBL. 24 REF.Article

STUDIES OF THE ANEMIA OF KALA-AZAR IN 68 CHILDHOOD CASES. SPECIFIC ANTIPARASITIC CHEMOTHERAPY IS THE MOST EFFECTIVE TREATMENT.HICSONMEZ G; OZSOYLU S.1977; CLIN. PEDIATR.; U.S.A.; DA. 1977; VOL. 16; NO 8; PP. 733-736; BIBL. 21 REF.Article

Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central IranMOHAMMADZADEH, Mahmoud; BEHNAZ, Fatemah; GOLSHAN, Zahra et al.Journal of infection and public health (Print). 2013, Vol 6, Num 2, pp 120-124, issn 1876-0341, 5 p.Article

Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasisCORDOBA, S; GANDOLFO CANO, M; AGUADO, M et al.Allergy (Copenhagen). 2012, Vol 67, Num 12, pp 1609-1611, issn 0105-4538, 3 p.Article

Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: comparison of conventional technique with mesotherapy gunMANSOUR NASSIRI KASHANI; SADR, Bardia; MOHAMMAD ALI NILFOROUSHZADEH et al.International journal of dermatology. 2010, Vol 49, Num 9, pp 1034-1037, issn 0011-9059, 4 p.Article

  • Page / 6